FEATURESThe Prevalence of Complementary and Integrative Health Approach Use and Quality of Life Among Patients With Heart Failure A Cross-sectional, Descriptive, and Comparative StudyGok Metin, Zehra PhD, RN; Gulbahar, Merve RNAuthor Information Internal Medicine Nursing Department, Faculty of Nursing, Hacettepe University, Ankara, Turkey. Correspondence: Zehra Gok Metin, PhD, RN, Internal Medicine Nursing Department, Faculty of Nursing, Hacettepe University, Samanpazari 06100, Ankara, Turkey ([email protected]). The authors would like to thank all the participants. Without their voluntary participation, this study would not have been possible. Both the authors contributed to conception and design of the study, acquisition of data, interpretation of data, drafting the article, revising the article critically for important intellectual content, and final approval of the version to be submitted. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Holistic Nursing Practice: May/June 2021 - Volume 35 - Issue 3 - p 123-132 doi: 10.1097/HNP.0000000000000442 Buy Metrics Abstract This study aimed to determine the prevalence of complementary and integrative health approach (CIHA) use in patients with heart failure (HF) and compare quality of life (QoL) between CIHA users and nonusers. This was a cross-sectional, descriptive, and comparative study including 130 patients with HF in Turkey. The data were collected using the sociodemographic and CIHA information form and the Kansas City Cardiomyopathy Questionnaire (KCCQ). The mean age was 64.51 ± 10.40 years. Furthermore, 26.1% of the participants had used at least one form of CIHA in the previous year. The most used CIHA was herbal therapies (94.2%). The total scores of the KCCQ were 47.70 ± 9.50 in the study, and a statistically significant difference was found in the total scores of the KCCQ between CIHA users and nonusers. The findings of this study revealed that more than a quartile of patients with HF used at least one form of CIHA. Further prospective studies are warranted to follow up with patients having HF who use any form of CIHA for a longer period and determine other parameters that directly influence QoL. © 2021 Wolters Kluwer Health, Inc. All rights reserved.